Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment

Objectives We evaluated changes in oral DM medication adherence and persistence, as well as glycemic control for the year prior to breast cancer (BC) diagnosis (Year −1), during BC treatment, and in subsequent years.